EMA Under Pressure Again As Staff Losses Worsen
The agency will focus on priority areas and operational efficiencies
Higher than expected staff losses due to the relocation to Amsterdam are posing challenges for the European Medicines Agency as it prepares to implement new EU legislation, and it is having to further prioritize its business activities. But the agency's planned move to a permanent HQ in the Dutch capital is still on track.
You may also be interested in...
The European Medicines Agency has taken possession of its new HQ in Amsterdam and has hired 77 new staff members to make up for the severe staff losses it has witnessed on account of Brexit.
Practically all centralized marketing authorizations held in the UK have now been moved to the EU, but Brexit and the European Medicines Agency’s relocation to Amsterdam are still causing the EMA some staffing and resource headaches.
Industry representatives told a House of Lords committee about continuing Brexit-related problems such as the extra work involved in checking compliance with the EU Falsified Medicines Directive and the drawbacks of a proposed “dual regulatory regime.”